CoChat

Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus

Open access
Matthaei, S., Bierwirth, R., Fritsche, A., Gallwitz, B., Häring, H.-U., Joost, H.-G., Kellerer, M., Kloos, Ch., Kunt, T., Nauck, M., Schernthaner, G., Siegel, E., Thienel, F. · 2009 · Experimental and Clinical Endocrinology & Diabetes
Cited by 91

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Contents Foreword 522 1. Antihyperglycaemic treatment of type 2 diabetes mellitus 523 1.1 Oral antidiabetic drugs 523 1.1.1 Non-β-cytotropic oral antidiabetic drugs 523 1.1.1.1 Metformin 523 1.1.1.2 Alpha-glucosidase inhibitors (acarbose, miglitol) 526 1.1.1.3 PPAR-γ-ligands (rosiglitazone, pioglitazone) 528 1.1.1.4 Combination therapy with non-β-cytotropic oral antidiabetic drugs 531 1.1.2 β-cytotropic medications: potassium channel blockers 531 1.1.2.1 Sulphonylureas 531 1.1.2.2 Sulphonylurea analogues (repaglinide, nateglinide) 533 1.1.2.3 Combination therapy with non-β-cytotropic oral antidiabetic drugs 534 1.1.3 DPP-4 inhibitors 534 1.2. Injectable therapies 538 1.2.1 Incretin mimetics (exenatide) 538 1.2.2 Insulin therapy 539 1.2.2.1 Indication 539 1.2.2 2 Blood glucose self-monitoring 540 1.2.2.3 Application 540 1.2.2.4 Insulin administration 540 1.2.2.5 Conventional therapy 540 1.2.2.6 Intensified conventional insulin therapy 541 1.2.2.7 Combination treatment with insulin and oral antidiabetic drugs 541 1.2.2.8 Side-effects of insulin therapy 542 2. Flowchart of antihyperglycaemic treatment of type 2 diabetes 543 2.1 Legend to flowchart 544 3. References 545 4. Appendix 1: Statement by the DDG regarding the results of the ACCORD and ADVANCE trials 553 1 Note: This updated version takes into account all evidence that was published prior to the end of 06/2008, as well as all new approvals/indications prior to the same date.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0029-1239559

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Metadata

Authors
Matthaei, S., Bierwirth, R., Fritsche, A., Gallwitz, B., Häring, H.-U., Joost, H.-G., Kellerer, M., Kloos, C., Kunt, T., Nauck, M., Schernthaner, G., Siegel, E., & Thienel, F.
Venue
Experimental and Clinical Endocrinology & Diabetes
Published
2009-10
Volume
117
Issue
09
Pages
522-557
ISSN
  • 0947-7349 (ISSN-L)
  • 1439-3646
OpenAlex
W219049085
Cited by
91
References
42
FWCI
8.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1055/s-0029-1239559
The paper
Matthaei, S., Bierwirth, R., Fritsche, A., Gallwitz, B., Häring, H.-U., Joost, H.-G., Kellerer, M., Kloos, C., Kunt, T., Nauck, M., Schernthaner, G., Siegel, E., & Thienel, F. (2009). Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. https://doi.org/10.1055/s-0029-1239559

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.